Abstract
Aims
Bilateral chylothoraces are rare but potentially life-threatening complications of neck dissections (ND). The condition is generally treated with a combination of dietary, medical, procedural, and surgical approaches. The aim of this review is to highlight the management options currently utilized in clinical practice and propose a management algorithm for this condition.
Methods
In accordance to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines; utilizing the Pubmed, EMBASE, and Web of Science databases, a systematic review of all available literature on bilateral chylothoraces was conducted. Primary outcomes measures included clinical presentations and type of neck dissection performed with interventions employed to manage the condition. Secondary outcome measures included the time to resolution alongside patient outcomes.
Results
We identified 37 patients (female n = 27, male n = 10) who presented with bilateral chylothoraces within the years 1951–2018. The mean age was 51.4 ± 16.5 years within the age ranges of 17–78 years. Most common pathologies included papillary thyroid carcinoma (n = 16), squamous cell carcinoma (SCC) of the larynx (n = 3), supraglottic SCC (n = 3). Left sided ND was done in (n = 18); bilateral ND in (n = 17); central/left ND in (n = 2). Chylothorax was treated by surgery in n = 10, n = 5 of which performed lymph node embolization; and n = 5 used lymph node ligation. Resolution was found in all cases. Discharge times ranged from 2 to 40 days.
Conclusions
This systematic review highlights the different management modalities in treating bilateral chylothoraces alongside providing a decision algorithm in treating the condition by suggesting diagnostic tools and management modalities to optimize patient care.
Keywords: Bilateral chylothorax, Neck dissection, Thoracic duct, Surgical management, Octreotide
Introduction
Chylothorax is defined as the presence of chyle in the pleural space. It is an uncommon complication after neck dissection but has a significant morbidity and mortality rate [1]. Chyle leaks can be identified either during surgery or in the first few days following surgery by observing increased lymphatic fluid buildup in the drainage. To achieve proper management, the diagnosis should be done early as chyle leak can affect the healing process and lead to poor wound healing, electrolytes disturbances, and cardiopulmonary complications [2, 3].
Bilateral chylothoraces are an even rarer entity with incredibly limited reports in available literature, in which chyle infiltrates the pleural space bilaterally. Neck dissections are surgical procedures used to both diagnose and treat cancer in the head and neck region. In general, a neck dissection should be used to treat any disease with clinically positive nodes or advanced tumors in node negative disease [4].
Due to the rarity and limited information available on bilateral chylothoraces, we intend to provide further understanding of the condition by systematically reviewing the available literature and discussing the management, investigations, and treatment modalities of the condition alongside proposing a management algorithm.
Methods
A systematic search using the databases of PubMed, Embase and Web of Science was conducted, looking for all articles reporting cases of bilateral chylothoraces. The search terms included “bilateral chylothorax” and “chylothorax” and the review period was restricted from January 1, 1955, to June 1, 2023. Each abstract was screened for possible inclusion by two reviewers independently (S.H, J.H). Articles were only included if both reviewers independently determined that all inclusion criteria were met. If a consensus was not reached, a third author was consulted. Two authors performed data extraction (F.I, A.A).
Inclusion/Exclusion Criteria
Inclusion criteria included all levels of scientific evidence, any treatment option, human studies, both genders and any age group. The following criteria were used for exclusion: articles of unrelated diagnosis, articles available in abstract form only and non-English articles.
Intervention
Any treatment strategy for bilateral chylothoraces, including conservative, medical, surgical, and any other interventions.
Comparator/Control
No comparison or control group was required for inclusion in this review.
Primary Outcomes
Studies were required to report clinical presentations and the type of neck dissection done and the treatments and interventions used to manage the condition. Ideally, studies provided the length of stay in the hospital quantified by postoperative days spent as an inpatient.
Secondary Outcomes
We also extracted data on the duration it would take for the bilateral chylothoraces to resolve or significantly improve following treatment or intervention, alongside extracting data on the outcomes of the provided management. The data was extracted and then quantitatively and descriptively documented in Table 1.
Table 1.
Table highlighting available cases of bilateral chylothoraces
| Author(s) | Year | Age | Sex | Identified Lesions | Side of neck dissection | Extent of dissection | Chyle Detected Intraoperatively? | Resolved? | Diagnosis | Treatment/duration | Surgical intervention needed? | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sharma et al | 2018 | 41 | Female | Thyroid papillary carcinoma | Left sided | Left central neck dissection | No | Yes | CXR showed BL pleural effusion POD 3 + Pleural fluid analysis showed a triglyceride level of 1996 mg/dL | BL pigtail insertion POD 3 + fat free diet | No | Resolution and discharged |
| Hayashibara et al | 2016 | 48 | Female | Thyroid papillary carcinoma | Left sided | Left cervical LN dissection | No | Yes | CXR POD 4 | Bilateral thoracic cavity drainage + fat restricted diet + Octreotide POD 4 | No | Resolution POD 9, discharged POD 20 |
| Merki et al | 2016 | 54 | Male | Met. thyroid papillary carcinoma | Bilateral central and lateral ND on the left side | Bilateral central and lateral ND on the left side | No | Yes | Thoracic CT scan showed right side pulmonary + BL pleural effusions + RT side thoracocentesis (chylous fluid) | BL thoracic drainage and TPN was started for a total of 18 days | No | Resolution POD 20, discharged POD 24 |
| Singh et al | 2016 | 61 | Female | Left lower alveolus well differentiated squamous cell carcinoma | Left sided | Left neck dissection LN level 1–4 | Yes | Yes | CXR, BL pleural effusion POD 2 + diagnostic pleural tap (drained fluids sent for chylomicron that was elevated) | Pleurocentesis POD 2 + left sided chest tube (removed POD 5) + fat free through Ryles tube and high protein diet | No | Resolution and discharged POD 10 |
| Matani et al | 2015 | 62 | Male | Squamous cell cancer of the larynx | Bilateral selective neck dissection | Bilateral selective neck dissection | Yes | Yes | CXR showed BL atelectasis + CT scan showed BL pleural effusions. Thoracentesis of the right chest (transudative effusions with triglyceride levels of 768 mg / dl. next day US confrimed the presence of BL chylothorax.) | Left chest tube + Octreotide + MCT + TPN | No | Resolution POD 13 |
| Runge et al | 2014 | 40 | Female | Thyroid papillary carcinoma | Bilateral | Cervico-central and cervico-lateral lymphadenectomy | No | Yes | CT scan showed massive BL pleural effusions POD 2 | Bilateral thoracic drainages + TPN & Octreotide (POD 2 started) | Thoracic duct ligation POD 4 | Resolution POD 9, discharged POD 11 |
| Parvinian et al | 2013 | 54 | Male | Laryngeal squamous cell carcinoma | Bilateral | Bilateral neck dissection | Yes | Yes | CT imaging of the chest revealed large BL pleural effusions with compressive atelectasis POD 3 + Diagnostic left thoracentesis (Aspirated fluids contained triglyceride levels of 200 mg/dl) | BL thoracentesis POD 3 + conservative (failed) | Yes/POD 5 surgical exploration failed to identify the source, TDE & intranodal lymphangiography POD 7, repeated after 11 days | Resolution POD 21 (Discharged in stable condition 4 days post-second TDE procedure) |
| Lizy et al | 2013 | 48 | Female | Papillary thyroid carcinoma | Left | Left side LN dissection | Yes (thoracic duct injury) | Yes | Synchronous BL Chylous leak POD 2 | CCDT (chest closed drainage tubes) + TPN | No | Resolution POD 8 |
| Lizy et al | 2013 | 31 | Female | Papillary thyroid carcinoma | Bilateral | Bilateral LN dissection | Yes | Yes | Synchronous BL chyle leak POD 3 | CCDT + TPN | No | Resolution POD 10 |
| Lizy et al | 2013 | 40 | Female | Papillary thyroid cacinoma | Bilateral | Bilateral LN dissection | Yes | Yes | Synchronous BL chyle leak POD 2 | TPN | Yes POD 3 (Thoracic duct ligation and drainage tube reinsertion under local anasthesia in cervical region) | Resolution POD 19 |
| Lizy et al | 2013 | 65 | Female | Papilary thyroid cacinoma | Central and left sided | LN dissection central and left | Yes | Yes | Synchronous BL chyle leak POD 8 | CCDT + TPN | No | Resolution POD 12 |
| Prabhu et al | 2012 | 58 | Male | Left-sided, oropharyngeal squamous cell carcinoma | Left sided | Left-sided modified radical neck dissection | No | Yes | CXR confirmed BL pleural effusions POD 3 + pleural tap revealed chylothorax | Aspirating the collection every day for a week, a fat-free diet, pressure dressings, and Octreotide for 14 days | No | Resolution |
| Tian et al | 2012 | 40 | Female | Thyroid papillary carcinoma | Bilateral | Bilateral lateral neck dissection | Injured and transfixed, but there was no intraoperative chyle leakage after transfixion | Yes | CXR showed large, BL pleural effusions POD 4 + diagnostic thoracentesis | Diagnostic thoracentesis + Bilateral closed drainage tubes were inserted POD 4 + TPN until POD 7 | No | Left chest tube removed POD 11, right one on POD 19. Resolution POD 22 |
| Tian et al | 2012 | 31 | Female | Thyroid papillary carcinoma | Bilateral | Bilateral lateral neck dissection | No | Yes | US findings confirmed BL moderate pleural effusion + diagnostic thoracentesis was performed on the right side POD 3 + a diagnostic thoracentesis was performed on the left side | Bilateral thoracentesis + drainage tube (R. side POD 3, L. side POD 4) + TPN POD 3 | No | Resolution POD 10 |
| Zhang et al | 2012 | 78 | Female | Supraglottic squamous cell carcinoma | Bilateral | Total laryngopharyngectomy + bilteral modified radial neck dissection | No | Yes | CXR BL pleural effusions + pulmonary edema POD 2 + fluid analysis revealed triglyceride levels of 283.4 mg/dl and were + ve for chylomicrons | BL pigtail thoracostomy tubes POD 3 + TPN for 3 days and MCT tube feedings | Yes/ POD 24 developed wound dehiscent (surgical exploration with thoracic duct ligation) | Resolution and discharged POD 40 |
| Soodin et al | 2010 | 65 | Female | Nodular malignant melanoma, developed multiple left sided cervical lymph nodes | Left sided | Left sided modified radical neck dissection | Yes | Yes | CXR + Thoracic CT scan. BL pleural effusions POD 2 | Left sided pigtail POD 2 + MCT | No | Resolution POD 10 |
| Tallon-aguilar et al | 2010 | 38 | Female | Papillary thyroid carcinoma | Left central and cervicolateral LN dissection | Left central and cervicolateral LN dissection | No | Yes | Chest x-ray b/l pleural effusion POD 3 + left sided thoraceentesis | Left thoracic drain + TPN (failed) | Yes / Leakage at the thoracic duct at the level of brachiocephalic trunk with suturing and sealing with biological glue | Resolution |
| Han et al | 2009 | 42 | Female | Bilateral medullary thyroid cancer | Bilateral | Left modified radical and right modified neck dissection | Yes | Yes | CXR showed large, BL pleural effusion POD 8 + thoracentesis results were compatible with bilateral chylothoraces (triglyceride level 283 mg/dl) | BL thoracentesis + left sided chest tube insertion POD 8 + TPN | No | Resolution POD 13 and discharged |
| Khurana et al | 2009 | 17 | Female | Thyroid cancer | Bilateral | Bilateral modified neck dissection | No | Yes | CXR showed mediastinal widening & BL pleural effusions POD 1 | BL chest drainage POD 1 + Octreotide 8 h later + TPN started on 4th day | Surgical exploration only POD 3 | Resolution and discharged POD 12 |
| Patel et al | 2008 | 61 | Female | Subglottic squamous cell carcinoma | Bilateral | Bilateral selective neck dissection | No | Yes | Fluid analysis showed triglyceride levels of 56 mg/dl | - | Thoracic duct embolization POD 2 | Resolution |
| Tsukahara et al | 2007 | 72 | Female |
Papillary adenocarcinoma of the thyroid |
Left sided | Left modified radical neck dissection | No | Yes | CXR revealed BL pleural effusions POD 2 + BL thoracentesis | BL thoracentesis + conservative TPN for 7 days | No | Resolution POD 8 |
| Tsukahara et al | 2007 | 64 | Male | Supraglottic carcinoma | Left sided | Left modified radical neck dissection | No | Yes | CXR, BL pleural effusions POD 4 + thoracentesis | Thoracentesis + BL thoracostomy tube + TPN > removed on the 12th day + Penrose drain was inserted POD 13 | No | Resolution |
| Tsukahara et al | 2007 | 76 | Male | Tongue cancer | Bilateral | Bilateral modified radical neck dissection | No | Yes | CXR, BL pleural effusions POD 2 | Left thoracentesis + TPN + BL thoracostomy tube for R + L thoracostomy tubes were removed on the 6th and 11th POD, respectively./ 12 POD | No | Resolution |
| Bae et al | 2007 | 46 | Female | Thyroid papillary carcinoma | Left sided | Left lateral neck node dissection | No | Yes | CXR and CT showed large, bilateral pleural effusions POD 7 + diagnostic pleural tap aspirated milky fluid, triglyceride level 459 mg/dl | Bilateral pigtail catheters were inserted POD 7 + TPN with total enteric rest was started and continued for 2 weeks | No | Resolution and discharged POD 22 |
| Bae et al | 2007 | 47 | Female | Thyroid papillary carcinoma | Cervical dissection in central + left lateral part of neck | Cervical lymph node dissection in the central and left lateral part of the neck | No | Yes | Both CXR + CT showed bilateral pleural effusions POD 3 + a diagnostic pleural tap aspirated milky fluid with a triglyceride level of 959 mg/dl | Bilateral pigtail catheters were inserted POD 3 + peripheral parenteral nutrition and a low-fat diet. Continued for 9 POD | No | Resolution and discharged POD 9 |
| Srikumar et al | 2006 | 24 | Female | Poorly differentiated nasopharyngeal carcinoma | Left sided | Left radical neck dissection | Yes | Yes | CXR revealed large, bilateral pleural effusions POD 5 + pleural taps were compatible with BL chylothoraces. Three days later, the CT scan of the neck and chest was performed due to persistent chyle leak | BL thoracentesis and chest drains were inserted POD 5/Conservative (TPN) + Ocreortide for 2 weeks post re-exploration | Underwent re-exploration POD 8 (findings included an intact thoracic duct and a small collection of chyle in the posterior triangle of the neck. This was drained) | Resolution POD 14, discharged POD 23 |
| Busquets et al | 2004 | 70 | Male | Left neck mass squamous cell carcinoma | Left sided | Left radical neck dissection | No | Yes | High output chyle leak through suction drainage (3.5 L in 16 h) + CXR + BL pleural tabs | Conservative enteral MCT + Somatostatin for 10 days after surgical intervention | Thoracic duct ligation 16 h post-op | Resolution |
| Kamasaki et al | 2003 | 78 | Female | Tongue cancer | Bilateral | Left radical and right modified neck dissection | No | Yes | CXR showed a massive pleural effusion POD 1 + CT scan confirmed the presence of large pleural effusion POD 5 | Left thoracostomy tube POD 2 + RT sided thoracentesis POD 5 + TPN | No | Resolution POD 19 |
| Al-Sebeih et al | 2001 | 70 | Male | Squamous cell cancer ofthe larynx | Bilateral | Total laryngectomy and bilateral modified neck dissection | Yes | Yes | Chest radiograph revealed extensive BL pleural effusion POD 3 | Bilateral chest tubes were inserted POD3 + TPN, Somatostatin started POD 13 | No | Resolution POD 20 |
| Abdul Jabbar et al | 1995 | 35 | Female | Thyroid papillary carcinoma | Bilateral | Bilateral lymph node neck dissection | No | Yes | CXR showed large BL pleural effusions + diagnostic and therapeutic thoracentesis was performed | Bilateral thoracentesis POD 4 | No | Resolution and discharged POD 10 |
| B. Kent, III et al | 1993 | 24 | Female | Thyroid papillary carcinoma | Bilateral | Bilateral jugular, paratracheal, and upper mediastinal lymph node dissection & thymectomy | No | Yes | CXR revealed BL pleural effusions POD 3 | Rt thoracentesis POD 3, B/L chest tube + TPN POD 7 (6 weeks of medical Tx > failed) | Thoracoscopic ligation of the thoracic duct after 6 weeks of failed medical Tx | Discharged 2 days post-surgical intervention |
| Pace-Balzan et al | 1988 | 48 | Male | Cervical LN, a poorly differentiated squamous cell carcinoma | Left sided | Left radical neck dissection | No | Yes | A CXR on POD 7 showed large BL pleural effusions + BL thoracocentesis | Conservative + BL thoracentesis POD 7 | No | Resolution and discharged on POD 14 |
| Richard et al | 1985 | 44 | Male | Left floor of mouth oral ulcer (squamous cell carcinoma) | Left sided | En bloc left radical neck dissection | Yes | Yes | CXR, BL pleural effusions POD 8 + thoracentesis of the left side showed a triglyceride level of 319 mg per dl & fat droplets that stained with Sudan III stain | Left sided thoracentesis POD 8 & high nitrogen solution with MCT | No | Resolution POD 17, discharged POD 35 |
| HAR-EL et al | 1985 | 34 | Female | Papillary thyroid carcinoma | Left neck dissection | Low retroclavicular dissection | No | Yes | CXR showed BL pleural effusions POD 3 + POD 3 rt sided thoracentesis + a 2nd thoracocentesis + pleural biopsy POD 6 | POD 3 right sided thoracentesis + low triglyceride diet for 5 days | No | Resolution and discharged POD 10 |
| Saraceno et al | 1981 | 58 | Female | Left side floor of mouth (squamous cell carcinoma) | Left sided | Left sided radical neck dissection | Injured, laceration was sewn | Yes | CXR, BL pleural effusions POD 3 + the milky-white fluid, as suspected, proved to be chyle by Sudan red stain | Left sided thoracentesis POD 3, repeated BL thoracentesis after 8 h + BL thoracostomy after 48 h | No | Resolution and discharged |
| Coates et al | 1976 | 78 | Female | Supraglottic carcinoma | Left sided | Left neck dissection | Yes | Yes | Chest roentgenogram showed bilateral pleural effusion and basilar exudate POD 3 + left sided thoracentesis + RT sided thoracentesis POD 6 | Thoracentesis + MCT (by tube POD 7) | No | Resolution (POD 12 NGT removed and MCT started by mouth) |
| Frazell et al | 1951 | 61 | Female | Skin of the left face | Left sided | Left sided radical neck dissection | No | Yes | Roentgen ray showed BL pleural effusions POD 5 + thoracocentesis | Wound was opened and evacuation done POD 4/ BL thoracocentesis POD 5 + TPN | No | Resolution POD 17, discharged POD 26 |
Statistical Analysis
Highly heterogeneous results were anticipated secondary to significant variations in hospital protocols, treatments, and initial neck dissections done. Data pertaining to treatments and patients’ responses to such were extracted. If a specific post-operative date of discharge was acquired, it was then extracted and summarized in Table 1. We were unable to conduct a meta-analysis due to the significant limitations of studies and the heterogeneity of the included studies in terms of presentations, unique hospital protocols, and treatments alongside limited sample size.
Risk of Bias Assessment
Studies of all different types (case reports, case series, cohort, case–control and interventional studies) were included. For this reason, no specific quality assessment tool was used. Data that is unclear or ambiguous or that did not satisfy the inclusion criteria were excluded from analysis.
Results
A total of 37 cases were found. The earliest report of chylothorax post-neck dissection was in 1951, while the latest was reported in 2018. A total of 5 cases were reported twice during 2007 and 2013. In terms of cases’ characteristics, the mean age for all included participants was 51.4 ± 16.5 years. The youngest case was 17 years old while the oldest was 78 years. About 73.0% of cases were female (n = 27) while 27.0% were male (n = 10), as depicted in Table 1.
The most common sites of primary lesions were related to papillary thyroid carcinomas (43.2%). Other common sites included SCC of the larynx (8.1%), of the oral cavity (8.1%), and the supraglottis (8.1%).
Neck dissection was performed on the left side in 48.6% of cases, while 45.9% had bilateral neck dissections. Only 2 cases had a central and left neck dissection (5.4%). The majority of neck dissections were modified radical dissections (27.0%). Among operated patients, only 40.5% had an intraoperative chyle leak detected and repaired.
Amongst the included cases, x-rays were the most common modality for diagnosis (54.1%). On the other hand, CT scans and CT in combination with x-rays were utilized in 8.1% and 16.2% of cases, respectively. Ultrasound diagnosis was utilized only once among the 37 included cases. With respect to treatment, Drainage followed by TPN was the most utilized treatment modality (37.8%).
Surgical treatment was utilized in 10 cases, 50% used lymph node embolization while the other 50% used lymph node ligation. Fortunately, irrespective of treatment, resolution was achieved in all cases. Time to discharge ranged from 2 to 40 days.
Discussion
Chylothoraces secondary to neck dissections occur either iatrogenically or due to inflammatory reactions secondary to direct leakage of the thoracic duct [5]. Another cause is secondary to the unintentional ligation of the thoracic duct, leading to the eventual rupturing of the thoracic duct [6]. When a patient who recently underwent neck dissection presents with a pleural effusion, a chylothorax should be suspected [7]. Many chylothoraces may initially be treated as cases of fluid overload [8]. This may prolong management until a thoracentesis is ordered; thus correctly diagnosing the condition [9], highlighting the importance of keeping the entity as a differential diagnosis [10].
Upon draining the milky fluid, investigations that aid in the diagnosis of the entity include Sudan III/IV staining, triglyceride quantification, and lipoprotein electrophoresis to detect any chylomicrons. Triglyceride levels of > 110 mg/dL strongly suggest the presence of chyle in the sample [11]. Serial chest radiographs should then be utilized to monitor the progression of the discovered entity [9].
Management of a chylothorax can be achieved via numerous methods ranging from dietary modifications to the use of various medications or the utilization of minimally invasive interventions and surgical ligation of the thoracic duct. Approaches to managing the condition include dietary modifications to correct electrolyte imbalances, chemical pleurodesis with the thoracostomy tubes, and thoracic duct ligation [12].
Dietary modifications in managing the condition include placing the patient on a low-fat diet (< 10 g a day), medium-chain triglyceride diet, and total parenteral nutrition in that sequence [12]. Medications such as Somatostatin, Octreotide, and Midodrine to prevent chyle formation have also been reported to be helpful in managing the entity [13, 14]. Alternative managements such as injected fibrin glue have limited supporting data [15]. Surgical techniques which include pleurovenous shunting, pleuroperitoneal shunting, and thoracic duct embolization also report successful outcomes [16, 17]. Most patients will benefit the most from a step-wise approach of conservative approaches to more invasive interventions if required [18]. Failing to manage the condition conservatively leads to the need for surgical interventions. Uchida et al. discovered that intervening in the early postoperative stage without pleurodesis yielded best results on patients who drained more than 500 ml/day despite being on a low fat diet; therefore surgical intervention must be early for cases of persistent chyle leakage [19].
The clinical guidelines that determine the mode and criteria for surgical interventions for prolonged chyle leakage is variable amongst institutions, with some suggesting that chest drains of over 1500 ml/day in adults or 100 ml/kg body weight in children or chyle leakages at rates of more than 1000 ml/day for 5 days, or chyle leaks that extend more than 2 weeks in duration, are appropriate criteria for surgical intervention. [20–23].
In the extracted data in Table 1, 27 patients were managed conservatively whilst 10 required surgical interventions. The majority of conservative interventions started off with dietary modifications and the insertion of thoracotomy tubes, with Octreotide being added as an adjuvant for some patients. Interventions were started immediately or within 24 h of discovering the condition via investigations. Most non-surgical patients were discharged within two weeks of management and all had eventual resolution of their symptoms. Of the surgical patients, a majority of the procedures involved thoracic duct ligation as the mainstay approach after re-exploration was done, with interventions generally occurring within 12–48 h after starting conservative managements. All patients achieved resolutions of their symptoms.
The limited sample size makes it difficult to highlight trends in the outcomes of patients based on the intervention used. This data demonstrates, however, the viability of all treatment methods if a reasonable step-wise approach is appropriately followed.
The aforementioned variability in management protocols would be aided by a management algorithm in treating bilateral chylothoraces which will be relevant to and apply to the management of unilateral chylothoraces, as demonstrated via a flow diagram in Fig. 1.
Fig. 1.
Proposed algorithm in treating bilateral chylothoraces
Conclusion
Bilateral chylothoraces post-neck dissections are an incredibly rare entity and have only been reported in less than 50 cases in available literature. In patients in which there is no obvious chyle leak, it is imperative to consider bilateral chylothorax as a differential in a patient with a postoperative pleural effusion that is non-responsive to diuresis, and to investigate for it accordingly.
Managing the condition involves a multidisciplinary approach that employs both medical and surgical investigations for post-operative patients. This is provided in a stepwise approach for patients that is provided in a multidisciplinary manner.
Funding
The authors have no financial interests to declare.
Conflict of interest
The authors have no conflicts of interests to declare.
Footnotes
Abstract has been submitted to the Canadian society of Otolaryngology-Head and Neck Surgery Meeting (CSO-HNS) meeting in Montreal June 2024–Pending decision.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.De Beer HG, Mol MJ, Janssen JP (2000) Chylothorax. Neth J Med 56(1):25–31. 10.1016/s0300-2977(99)00114-x [DOI] [PubMed] [Google Scholar]
- 2.Maldonado A, Cartin-Ceba R, Hawkins FJ, Ryu JH (2010) Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 339(4):314–318. 10.1097/MAJ.0b013e3181cdcd6c [DOI] [PubMed] [Google Scholar]
- 3.Frazell E, Harrold CC Jr, Rasmussen L (1951) Bilateral chylothorax; an unusual complication of radical neck dissection with recovery. Ann Surg 134(1):135–137. 10.1097/00000658-195107000-00018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wistermayer P, Anderson KG. Radical Neck Dissection. [Updated 2023 Apr 30]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK563186/# [PubMed]
- 5.Runge T, Borbély Y, Candinas D, Seiler C (2014) Bilateral chylothorax following neck dissection: a case report. BMC Res Notes 7:311. 10.1186/1756-0500-7-311 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kamasaki N, Ikeda H, Wang ZL, Narimatsu Y, Inokuchi T (2003) Bilateral chylothorax following radical neck dissection. Int J Oral Maxillofac Surg 32(1):91–93. 10.1054/ijom.2002.0312 [DOI] [PubMed] [Google Scholar]
- 7.Huggins JT (2010) Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31(6):743–750. 10.1055/s-0030-1269834 [DOI] [PubMed] [Google Scholar]
- 8.Morjaria JB, Aslam I, Johnson B, Greenstone MA, Kastelik JA (2015) Bilateral chylothorax: an unusual complication of cervical rib resection. Ther Adv Chronic Dis 6(1):29–33. 10.1177/2040622314552072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rudrappa M, Paul M (2023) Chylothorax. [Updated 2023 Feb 21]. In: StatPearls. StatPearls Publishing, Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK459206/
- 10.Pinar E, Oncel S, Calli C, Guclu E, Tatar B (2008) Pharyngocutaneous fistula after total laryngectomy: emphasis on lymph node metastases as a new predisposing factor. J Otolaryngol Head Neck Surg 37(3):312–318 [PubMed] [Google Scholar]
- 11.Ur Rehman K, Sivakumar P (2022) Non-traumatic chylothorax: diagnostic and therapeutic strategies. Breathe (Sheff) 18(2):210163. 10.1183/20734735.0163-2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Takuwa T, Yoshida J, Ono S, Hishida T, Nishimura M, Aokage K, Nagai K (2013) Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J Thorac Cardiovasc Surg 146(3):571–574. 10.1016/j.jtcvs.2013.04.015 [DOI] [PubMed] [Google Scholar]
- 13.Anthony L, Freda PU (2009) From somatostatin to octreotide LAR: evolution of a somatostatin analogue. Curr Med Res Opin 25(12):2989–2999. 10.1185/03007990903328959 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Papoulidis P, Vidanapathirana P, Dunning J (2018) Chylothorax, new insights in treatment. J Thorac Dis 10(Suppl 33):S3976–S3977 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nguyen D, Tchervenkov CI (1994) Successful management of post- operative chylothorax with fibrin glue in a premature neonate. CanJ Surg 37:158–160 [PubMed] [Google Scholar]
- 16.Pospiskova J, Smolej L, Belada D, Simkovic M, Motyckova M, Sykorova A, Stepankova P, Zak P (2019) Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders. Orphanet J Rare Dis 14(1):9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Yang RF, Liu TT, Wang P, Zhang RQ, Li C, Han B, Gao XX, Zhang L, Jiang ZM (2018) Ligation of thoracic duct during thoracoscopic esophagectomy can lead to decrease of T lymphocyte. J Cancer Res Ther 14(7):1535–1539 [DOI] [PubMed] [Google Scholar]
- 18.Furukawa M, Hara A, Miyazaki R, Yokoyama S, Hayashi M, Tao H, Okabe K (2018) Assessment of fat-free diet for postoperative chylothorax. Kyobu Geka 71(13):1063–1065 [PubMed] [Google Scholar]
- 19.Uchida S, Suzuki K, Hattori A, Takamochi K, Oh S (2015) Surgical intervention strategy for postoperative chylothorax after lung resection. Surg Today 46(2):197–202. 10.1007/s00595-015-1183-6 [DOI] [PubMed] [Google Scholar]
- 20.Marts BC, Naunheim KS, Fiore AC, Pennington DG (1992) Conserva- tive versus surgical management of chylothorax. Am J Surg 164:532–535 [DOI] [PubMed] [Google Scholar]
- 21.Dugue L, Sauvanet A, Farges O, Goharin A, Le Mee J, Belghiti J (1998) Output of chyle as an indicator of treatment for chylothorax complicating oesophagectomy. Br J Surg 85:1147–1149 [DOI] [PubMed] [Google Scholar]
- 22.Selle JG, Snyder WH 3rd, Schreiber JT (1973) Chylothorax: indications for surgery. Ann Surg 177:245–249 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cerfolio RJ, Allen MS, Deschamps C, Trastek VF, Pairolero PC (1996) Postoperative chylothorax. J Thorac Cardiovasc Surg 112(5):1361–1365. 10.1016/S0022-5223(96)70152-6. (discussion 1365-6) [DOI] [PubMed] [Google Scholar]

